Review article · 2026 · Open access
Systematic Review and Meta-Analysis on Bacteriophage Therapy Against Multidrug-Resistant Bacteria
International Journal of Drug Delivery Technology, 16(68s) · Published 14 October 2026 · DOI 10.25258/ijddt.16.68s.16
In brief
“Systematic Review and Meta-Analysis on Bacteriophage Therapy Against Multidrug-Resistant Bacteria” is a 2026 review article, published in International Journal of Drug Delivery Technology. OpenAlex counts 0 citations as of 15 November 2026. It is open access: the full text is free to read at International Journal of Drug Delivery Technology.
- Citations
- 0
Abstract
The rise in multidrug-resistant bacteria (MDRB) has become one of the greatest threats to today's healthcare systems.Antimicrobial resistance has been a continuous phenomenon, diminishing the effectiveness of conventional antimicrobial drugs and resulting in increased morbidity, mortality and healthcare costs globally.Due to its selective targeting to pathogenic bacteria, disruption of biofilms and increased bacterial susceptibility to antibiotic-based treatment, the use of bacteriophage therapy is a promising alternative.This study was designed to assess efficacy and safety of bacteriophage therapy in the treatment of multidrug-resistant bacterial infections by conducting a systematic review and meta-analysis.Secondary data was retrieved from PubMed, Scopus, Web of Science and Google Scholar.The published literature from 2015-2026 was screened based on the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines.Forty-two studies consisting of clinical trials, observational studies, case series and compassionate-use reports were included, involving 2,134 patients.Random-effects meta-analysis was used for quantitative synthesis.The clinical improvement rate was 79.4% (pooled) while bacterial eradication was seen in 84.1% of the patients.Combination therapy (phage + antibiotics) was more effective than the use of phages alone.Adverse events were rarely reported and were mostly mild.There was some degree of heterogeneity between studies due to differences in treatment protocols and bacterial pathogens.The results show that the bacteriophage therapy is a potential treatment method in fighting MDR infections.However, issues such as standardization, regulation, phage resistance and small randomized clinical trials limit the use of these agents in the clinic.The potential for future improvements in engineered bacteriophages, personalized phage cocktails and delivery systems will help make bacteriophage therapy a part of modern antimicrobial therapies.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Systematic Review and Meta-Analysis on Bacteriophage Therapy Against Multidrug-Resistant Bacteria. (2026). International Journal of Drug Delivery Technology, 16(68s). https://doi.org/10.25258/ijddt.16.68s.16
MLA 9
“Systematic Review and Meta-Analysis on Bacteriophage Therapy Against Multidrug-Resistant Bacteria.” International Journal of Drug Delivery Technology, vol. 16, no. 68s, 2026. https://doi.org/10.25258/ijddt.16.68s.16.
Chicago
2026. “Systematic Review and Meta-Analysis on Bacteriophage Therapy Against Multidrug-Resistant Bacteria.” International Journal of Drug Delivery Technology 16 (68s). https://doi.org/10.25258/ijddt.16.68s.16.
Harvard
(2026) ‘Systematic Review and Meta-Analysis on Bacteriophage Therapy Against Multidrug-Resistant Bacteria’, International Journal of Drug Delivery Technology, 16(68s). doi:10.25258/ijddt.16.68s.16.
IEEE
“Systematic Review and Meta-Analysis on Bacteriophage Therapy Against Multidrug-Resistant Bacteria,” International Journal of Drug Delivery Technology, vol. 16, no. 68s, 2026, doi: 10.25258/ijddt.16.68s.16.
BibTeX
@article{anon2026systematic,
title = {{Systematic Review and Meta-Analysis on Bacteriophage Therapy Against Multidrug-Resistant Bacteria}},
journal = {International Journal of Drug Delivery Technology},
year = {2026},
volume = {16},
number = {68s},
doi = {10.25258/ijddt.16.68s.16},
url = {https://doi.org/10.25258/ijddt.16.68s.16}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Life Sciences › Immunology and Microbiology › Virology › Bacteriophages and microbial interactions
- phage therapy
- multidrug-resistant bacteria
- antimicrobial resistance
- bacterial killing
- phage resistance
- engineered bacteriophages
Work with this paper
Most-cited papers in Immunology and Microbiology
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Ulrich K. Laemmli · Nature · 1970 · 249,784 citations
- Atherosclerosis — An Inflammatory DiseaseRussell Ross · New England Journal of Medicine · 1999 · 21,957 citations
- Continuous cultures of fused cells secreting antibody of predefined specificityGeorges Köhler, César Milstein · Nature · 1975 · 17,450 citations
- Inflammation and cancerLisa M. Coussens, Zena Werb · Nature · 2002 · 15,462 citations
- Dendritic cells and the control of immunityJacques Banchereau, Ralph M. Steinman · Nature · 1998 · 14,526 citations
Questions about this paper
How do I cite this paper in APA style?
Systematic Review and Meta-Analysis on Bacteriophage Therapy Against Multidrug-Resistant Bacteria. (2026). International Journal of Drug Delivery Technology, 16(68s). https://doi.org/10.25258/ijddt.16.68s.16
How many times has this paper been cited?
0 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access: read the free full text at International Journal of Drug Delivery Technology.
What is the DOI of this paper?
10.25258/ijddt.16.68s.16. The permanent link is https://doi.org/10.25258/ijddt.16.68s.16.
Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.